DVA: DaVita Inc. - Summary | Jitta

DaVita Inc.

NYSE:DVA

Price
$198.66
Loss Chance
44.6%
4.82JITTA SCORE
35.30%Under Jitta Line
Jitta Ranking
43 / 716
547 / 4,218
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (55)
Recent Business Performance (29)
Financial Strength (52)
Return to Shareholders (45)
Competitive Advantage (51)
Jitta Signs
Revenue and EarningConsistent Growth in the past 5 years
Recent Business PerformanceEarning Growth Last Quarter (YoY)
Share RepurchaseEvery Year
Interest Coverage RatioVery Good
Cash Conversion CycleLess than 60 days
Debt LevelHigh Long Term Debt
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
4.82
35.30%
3.05
207.29%
Health Care Services
6.32
15.40%
2.81
14.74%
5.29
9.11%
COMPANY DESCRIPTION
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.